Related Experiment Video
Updated: Jun 30, 2026

Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors
Published on: June 7, 2016
Effect of repetitive icv injections of ANG II on c-Fos and AT(1)-receptor expression in the rat brain
E Moellenhoff1, A Blume, J Culman
1Institute of Pharmacology, University of Kiel, Hospitalstrasse 4, 24105 Kiel, Germany.
This study examines how repeated daily brain injections of the hormone angiotensin II affect gene activity and receptor levels in specific rat brain regions compared to a single injection. The researchers found that while some immediate gene responses decrease over time, the number of receptors for this hormone actually increases, suggesting a complex adaptive mechanism in the brain.
Area of Science:
- Neuroendocrinology research within ANG II signaling pathways
- Molecular neuroscience and transcription factor regulation
Background:
Prior research has shown that angiotensin II influences neuroplasticity through the activation of inducible transcription factors within the central nervous system. That uncertainty drove interest in how these signaling pathways adapt to prolonged hormonal exposure. No prior work had resolved whether chronic stimulation leads to consistent gene activation or adaptive desensitization across key regulatory brain nuclei. It was already known that these specific regions are involved in fluid balance and cardiovascular control. This gap motivated an investigation into the differential effects of acute versus repeated hormonal administration. Prior studies often focused on single-dose responses, leaving the long-term molecular consequences unclear. The current literature lacks clarity on how constitutive transcription factors behave under these repetitive conditions. Researchers needed to determine if the observed changes occur at the transcriptional level or through receptor modulation.
Purpose Of The Study:
The aim of this study was to investigate the molecular effects of acute versus repetitive daily intracerebroventricular injections of ANG II over one week. The researchers sought to determine how chronic hormonal exposure influences the expression of inducible and constitutive transcription factors. This investigation addressed the lack of data regarding long-term neuroplastic responses to periventricular hormonal stimulation. The authors intended to map these changes across the median preoptic area, subfornical organ, and hypothalamic nuclei. They aimed to clarify whether repetitive stimulation leads to consistent activation or adaptive desensitization of signaling pathways. The study was motivated by the need to understand how the brain maintains homeostasis during prolonged hormonal signaling. The researchers hypothesized that chronic exposure would produce a distinct molecular profile compared to single-dose administration. Finally, the work aimed to identify potential intermediates involved in the regulation of the AT1 receptor during these adaptive processes.
Main Methods:
Review approach involved comparing acute versus once-daily intracerebroventricular administration of the hormone over a seven-day period. The investigators targeted the median preoptic area, subfornical organ, paraventricular nucleus, and supraoptic nucleus for analysis. Review approach utilized immunohistochemistry to localize protein expression patterns within these specific anatomical structures. The team employed Reverse Transcription Polymerase Chain Reaction to quantify transcriptional changes within the supraoptic nucleus. Review approach required comparing these results against control groups receiving only a single injection. The researchers assessed both inducible and constitutive transcription factors to determine the scope of the molecular response. Review approach focused on identifying changes in AT1 receptor density following the established treatment protocol. The study design allowed for the differentiation between transient and sustained molecular adaptations in the central nervous system.
Main Results:
Key findings from the literature demonstrate that c-Fos expression drops by approximately 50% in the MnPO, SFO, PVN, and SON after repetitive treatment. Key findings from the literature confirm that this reduction in c-Fos occurs at the transcriptional level as verified by RT-PCR in the SON. Key findings from the literature show that c-Jun exhibits novel expression in the SON, while other inducible factors like JunB, JunD, and Krox-24 remain stable. Key findings from the literature indicate that constitutive factors, including CREB, ATF-2, and SRF, show no significant alterations between single and repetitive stimulation. Key findings from the literature reveal that the AT1 receptor is consistently co-expressed with c-Fos and c-Jun across the studied regions. Key findings from the literature suggest an increase in the number of AT1 receptors in all four nuclei after chronic stimulation. Key findings from the literature establish that repetitive periventricular stimulation significantly modifies the expression profile of transcription factors compared to acute exposure. Key findings from the literature identify c-Fos and c-Jun as the primary intermediates involved in the transcription of the AT1 receptor.
Conclusions:
Synthesis and implications suggest that repetitive hormonal stimulation leads to a significant decline in c-Fos expression across multiple brain regions. The authors propose that this reduction reflects a desensitization process occurring at the transcriptional level. Synthesis and implications indicate that c-Jun expression increases specifically within the supraoptic nucleus following chronic stimulation. The researchers propose that c-Fos and c-Jun serve as primary mediators for the regulation of AT1 receptor transcription. Synthesis and implications highlight that the number of AT1 receptors increases in the examined nuclei after repeated exposure. The authors suggest that these molecular shifts represent a distinct adaptive response compared to acute activation. Synthesis and implications confirm that repetitive periventricular signaling fundamentally alters the transcriptional landscape of the brain. The researchers propose that these findings clarify the regulatory mechanisms underlying chronic angiotensin II signaling in the rat brain.
Frequently Asked Questions
The researchers propose that repetitive injections cause a 50% decrease in c-Fos expression in the MnPO, SFO, PVN, and SON. This decline indicates a desensitization process, which the authors confirmed occurs at the transcriptional level using RT-PCR analysis in the supraoptic nucleus.
The authors utilized immunohistochemical staining to visualize the AT1 receptor. They observed that this receptor is co-expressed with c-Fos and c-Jun, and its density increases in the MnPO, SFO, PVN, and SON following chronic stimulation compared to single-dose controls.
The researchers propose that transcriptional analysis is necessary to confirm desensitization. They specifically employed Reverse Transcription Polymerase Chain Reaction (RT-PCR) in the supraoptic nucleus to verify that the observed decline in c-Fos protein levels corresponds to reduced gene expression rather than protein degradation.
The authors examined inducible transcription factors like c-Jun, JunB, JunD, and Krox-24, alongside constitutive factors such as CREB and ATF-2. They found that only c-Jun showed novel expression in the supraoptic nucleus, while other factors remained unchanged between single and repetitive stimulation groups.
The researchers measured the expression of transcription factors and receptor density across the median preoptic area, subfornical organ, hypothalamic paraventricular nucleus, and supraoptic nucleus. They compared these measurements between rats receiving a single injection and those receiving daily injections for seven days.
The authors suggest that their findings demonstrate a shift in how the brain handles chronic versus acute hormonal signals. They propose that c-Fos and c-Jun act as major intermediates in the transcription of the AT1 receptor, providing a mechanism for long-term neuroplastic adaptation.
More Related Videos
08:44Continuous IV Infusion is the Choice Treatment Route for Arginine-vasopressin Receptor Blocker Conivaptan in Mice to Study Stroke-evoked Brain Edema
Published on: September 1, 2016
08:28Non-invasive Strategies for Chronic Manipulation of DREADD-controlled Neuronal Activity
Published on: August 25, 2019
Related Concept Videos
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System